发明申请
US20080167244A1 USE OF IL-28 AND IL-29 TO TREAT CANCER AND AUTOIMMUNE DISORDERS
有权
使用IL-28和IL-29治疗癌症和自身免疫性疾病
- 专利标题： USE OF IL-28 AND IL-29 TO TREAT CANCER AND AUTOIMMUNE DISORDERS
- 专利标题（中）： 使用IL-28和IL-29治疗癌症和自身免疫性疾病
-
申请号： US12030107申请日： 2008-02-12
-
公开(公告)号： US20080167244A1公开(公告)日： 2008-07-10
- 发明人: Sean Doyle , Kevin M. Klucher , Pallavur V. Sivakumar , Wayne R. Kindsvogel , Chung Chan
- 申请人： Sean Doyle , Kevin M. Klucher , Pallavur V. Sivakumar , Wayne R. Kindsvogel , Chung Chan
- 专利权人： ZymoGenetics, Inc.
- 当前专利权人： ZymoGenetics, Inc.
- 主分类号： A61K38/16
- IPC分类号： A61K38/16 ; A61P35/04
摘要：
Methods for treating patients with cancer and autoimmune disorders using IL-28 and IL-29 molecules. The IL-28 and IL-29 molecules include polypeptides that have homology to the human IL-28 or IL-29 polypeptide sequence and proteins fused to a polypeptide with IL-28 and IL-29 functional activity. The molecules can be used as a monotherapy or in combination with other known cancer and/or autoimmune therapeutics.
公开/授权文献
信息查询
IPC分类:
